NMD-VCell Neuromuscular Virtual Cell Research Platform Module: Browse · Evidence → perturbation → experiment → outcome NMD = neuromuscular disorders

Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible

View scientific status
Evidence freeze: 3 August 2026 Resource: v1.2.0-measured-dmd-evidence Schema: 1.1 Open release status →

Cell Context Explorer

Find which neuromuscular cell contexts are measured, bounded or still missing.

Filter ten released context records across DMD, FSHD, DM1 and SMA, then use the DMD ecosystem map to translate evidence coverage into the next testable cell-system question.

Module meaning contract

Browse · what this module can change

See all eight modules →
Question answeredWhich gene, cell compartment, dataset and measured context are relevant to the question?
Scope & evidence unitThe interactive cell-compartment map is DMD muscle context. Four-disease datasets and measured evidence are browsed through the disease atlas.A source-linked gene, dataset or compartment record with explicit provenance and biological/statistical unit.
ProducesA context map or stable evidence record that shows what is observed, contextual and missing.
Cannot establishNo cell-specific causal effect, cell–cell interaction estimate or perturbation-conditioned DMD fate is inferred from browsing.

Next handoffOpen a gene record, compare DMD candidates, or return to a disease module for disease-level evidence. Continue →

Measured-context inventory

A real context browser with statistical units and claim ceilings.

Each record names the dataset, analysis unit, observed result, permitted use and the highest claim it can support. Missing target-context outcome remains visible as a record.

Machine-readable registry →

10contexts shown

DMDMEASURED CORRECTION REFERENCE

Myogenic induction / DMD-locus correction

CTX-DMD-MYOGENIC-CORRECTION
Source
GSE272233
Unit structure
Biological repeat / sample; 3 repeats per group
Observed result21 samples; 24 background-specific dual-supported reversal pathways; 0 strict reversals shared across all 3 backgrounds.

Permitted use: DMD induction and locus-correction reference

Claim ceiling: No candidate-gene response prediction

Open the source-bounded module →
DMDMEASURED DISEASE REFERENCE

Patient skeletal muscle

CTX-DMD-PATIENT-MUSCLE
Source
PRJNA772047
Unit structure
Independent patient sample / pathway-level pseudobulk analysis
Observed result291 sample-level DMD disease pathways supported by CAMERA in the external patient-muscle reference.

Permitted use: External disease-pathway replication

Claim ceiling: No candidate-gene perturbation efficacy

Open the source-bounded module →
DMDMISSING REQUIRED OUTCOME

Candidate perturbation in DMD muscle

CTX-DMD-CANDIDATE-PERTURBATION
Source
No released outcome object
Unit structure
Required matched DMD/control biological repeats
Observed resultNo candidate has a qualifying independent perturbation outcome in a DMD muscle model yet.

Permitted use: Study design and predictability gating only

Claim ceiling: Prediction locked; absence is not a negative effect

Open the source-bounded module →
FSHDMEASURED DESCRIPTIVE

Patient myotube nuclei

CTX-FSHD-PATIENT-MYOTUBE
Source
GSE143452
Unit structure
8 samples from 1 FSHD2 and 1 control donor
Observed result32,273 nuclei; all 17 requested DUX4-axis genes detected; donor-general prevalence is not estimable.

Permitted use: Descriptive state stratification

Claim ceiling: No donor-general or patient treatment estimate

Open the source-bounded module →
FSHDINDUCED CELL LINE RESPONSE

Inducible DUX4 myoblast time course

CTX-FSHD-IDUX4
Source
GSE205421
Unit structure
4 culture wells per condition across 6 conditions
Observed result24 samples; 6,986 genes significant at 14 h using q < 0.05 and |log2FC| ≥ 1.

Permitted use: DUX4-response timing and experiment design

Claim ceiling: Cell-line response, not patient therapeutic efficacy

Open the source-bounded module →
DM1MEASURED CORRECTION REFERENCE

Isogenic repeat-corrected myoblast

CTX-DM1-ISOGENIC-MYOBLAST
Source
GSE127296
Unit structure
Independently derived clone; clone identity retained
Observed result8 clones; 163 differential splicing events at FDR < 0.05; clone effects remain a stated boundary.

Permitted use: Expression and splicing correction reference

Claim ceiling: Clones are not independent patients

Open the source-bounded module →
DM1MEASURED DISEASE REFERENCE

Patient skeletal muscle

CTX-DM1-PATIENT-MUSCLE
Source
GSE201255
Unit structure
Independent biopsy; repeat biopsies excluded
Observed result36 genes overlap the isogenic and patient splicing signals; global expression alignment is negligible (Spearman ρ = -0.039).

Permitted use: Patient expression/splicing comparison

Claim ceiling: No prognosis or treatment ranking

Open the source-bounded module →
SMAMEASURED INTERVENTION REFERENCE

Spinal organoid / ASO response

CTX-SMA-SPINAL-ORGANOID
Source
GSE290979 / GSE290980
Unit structure
Donor-derived line after technical aggregation
Observed result31 samples from 3 control, 2 SMA and 2 ASO-treated SMA lines; no global gene-expression reversal.

Permitted use: Human neural intervention-response design

Claim ceiling: No patient motor-outcome prediction

Open the source-bounded module →
SMAMEASURED RESIDUAL REFERENCE

Treated patient skeletal muscle

CTX-SMA-TREATED-MUSCLE
Source
GSE252128
Unit structure
Independent biopsy
Observed result8 treated SMA versus 7 control samples; 0 genes at q < 0.05 and |log2FC| ≥ 0.5; residual-module q-values exceed 0.30.

Permitted use: Residual muscle-module experiment design

Claim ceiling: Null threshold result is not proof of full correction

Open the source-bounded module →
SMAMEASURED DISEASE REFERENCE

Motor and cortical neurons

CTX-SMA-NEURONAL
Source
GSE302774
Unit structure
Independent culture replicate; n = 3 per condition and context
Observed resultKIF5A decreased concordantly in both neuronal contexts (log2FC approximately -1.31 in each).

Permitted use: Cross-neuronal disease-context comparison

Claim ceiling: No calibrated intervention or patient response

Open the source-bounded module →
Context inventoryDMD biological-system interpretation

Map layer

Read the same ecosystem through three scientific lenses.

Biology shows the role each compartment plays in tissue repair and remodeling.

Interactive concept map · status labels come from released objects
ECM
Injury
Perfusion
DMD muscleDisease ecosystemSelect a compartment
Myoblast → myotube

Myogenic lineage

Limited context
Biological role

Carries regeneration, fusion and contractile maturation—the lineage in which a functional DMD perturbation effect must ultimately be tested.

Decision-relevant questionDoes the perturbation change fusion, maturation or injury response differently in DMD and matched-control muscle cells?

Current evidence

  • Human myoblast fusion screen for 9 of 21 candidates
  • DMD-locus correction reference with 21 samples
  • Unperturbed 0/24/48/72-hour human-myogenic trajectory

Functional readouts needed

  • Fusion index
  • Myotube morphology
  • Membrane integrity
  • Calcium or contraction
  • Viability
Cross-cell consequences to testFAP / ECMImmune injury signalsVascular support
Current virtual-cell outputReference-state placement only. No calibrated DMD molecular or functional response is emitted.
Why prediction is lockedNo independent candidate perturbation has been repeated in a DMD muscle model.
Follow the measured trajectory

One result · three reading levels

Choose the explanation that matches your task.

Biologist

Each compartment changes the biological question and the readouts that matter. Only the myogenic lineage currently has a measured reference trajectory, and none has a calibrated DMD perturbation response.

Evidence availability checker

Choose a cell context and intervention

Measured · limited · not yet tested
Can this be answered?Not yet tested in DMD muscle
Direct evidenceObserved HepG2 response exists
Related contextLimited human-myoblast screen
Missing evidenceIndependent DMD muscle perturbation

What this means: NMD-VCell can assemble the evidence and define the next experiment, but it cannot yet emit a calibrated DMD response.